Clinical trial AZD 8205
A Phase I/IIa Multi-center, Open-label Master Protocol to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of AZD8205 in Participants with Advanced or Metastatic Solid Malignancies
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2a |
| Academic trial | Non |
| Sponsor | AstraZeneca |
| EudraCT Identifier | 2022-502759-70-01 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05123482 |
| Last update |